 |
|
|
| |
Glecaprevir/Pibrentasvir for the Treatment of Patients With Chronic Hepatitis C Virus Infection:
Updated Real-World Data From the German Hepatitis C-Registry
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-12 Boston
Johannes Wiegand1, Uwe Naumann2, Albrecht Stoehr3, Christoph Sick4, Christi ne John5, Gerlinde Teuber6, Willibold Schiff elholz7, Stefan Mauss8, Kristi na Lohmann9, Betti na König9, Andreas Pangerl9, Karl-Georg Simon10
1Clinic of Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany; 2UBN-Praxis, Berlin, Germany; 3IFI Studien und Projekte GmbH, Hamburg, Germany; 4Praxisonkologie Bremen, Bremen, Germany; 5Practi ce PD Dr. med. C John, Berlin, Germany; 6Practi ce PD Dr. med. G Teuber,
Frankfurt am Main, Germany; 7Gastroenterologische Schwerpunktpraxis, Augsburg, Germany; 8Center for HIV and Hepatogastroenterology, Dusseldorf, Germany; 9AbbVie Inc., North Chicago, Illinois, United States; 10MVZ Dres Eisenbach/Simon/Schwarz/Block, Leverkusen, Germany
|
| |
|
|
|
|
|
